ArticleCardiovascular diabetology2022

Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus.

Yuta Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.